Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (101-110 of 310) with videos related to

Pageof 31
Sort By:
Cancer|January 11, 2005
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCarlos Rodriguez-Galindo, Marcia Wofford, Robert P Castleberry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 10, 1999
Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cellA A Selyanko, J K Hadley, I C Wood, et al.
Circulation Research|May 23, 2001
Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongationB London, W Guo, Pan Xh, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
The Journal of Experimental Medicine|July 31, 2020
Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitorsTing Tao, Hui Shi, Meng Wang, et al.
Pediatric Blood & Cancer|May 31, 2020
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectVeronica Moroz, David Machin, Barbara Hero, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaborationChaim Kirby, Peter F Ambros, David Billiter, et al.
Blood Advances|December 28, 2023
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapyMichelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, et al.
Molecular Pharmacology|December 20, 2007
N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activatorA D Wickenden, J L Krajewski, B London, et al.
Pediatric Blood & Cancer|October 14, 2014
Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group reportTanya M Trippett, Cindy L Schwartz, R Paul Guillerman, et al.
Pageof 31

Showing results (101-110 of 310) with videos related to

Sort By:
Pageof 31
Cancer|January 11, 2005
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCarlos Rodriguez-Galindo, Marcia Wofford, Robert P Castleberry, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 10, 1999
Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cellA A Selyanko, J K Hadley, I C Wood, et al.
Circulation Research|May 23, 2001
Targeted replacement of KV1.5 in the mouse leads to loss of the 4-aminopyridine-sensitive component of I(K,slow) and resistance to drug-induced qt prolongationB London, W Guo, Pan Xh, et al.
Pediatric Blood & Cancer|July 24, 2008
Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) projectSteven G Dubois, Wendy B London, Yang Zhang, et al.
The Journal of Experimental Medicine|July 31, 2020
Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitorsTing Tao, Hui Shi, Meng Wang, et al.
Pediatric Blood & Cancer|May 31, 2020
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectVeronica Moroz, David Machin, Barbara Hero, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Development of an open-source, flexible framework for complex inter-institutional disparate data sharing and collaborationChaim Kirby, Peter F Ambros, David Billiter, et al.
Blood Advances|December 28, 2023
Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapyMichelle L Schoettler, Leslie Lehmann, Pei-Chi Kao, et al.
Molecular Pharmacology|December 20, 2007
N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activatorA D Wickenden, J L Krajewski, B London, et al.
Pediatric Blood & Cancer|October 14, 2014
Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group reportTanya M Trippett, Cindy L Schwartz, R Paul Guillerman, et al.
Pageof 31